M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine

DOI: 10.1080/2162402X.2018.1426519

Keywords: PD-L1, TGFβ, carcinoma, checkpoint blockade, tumor microenvironment, TWIST1, vaccine, adenovirus

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text